Nadine Tuaillon

Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor Cells <i>In vitro</i> and Controls Tumor Expansion <i>In vivo</i> via Low-Affinity Activating Fcγ Receptors

Jeffrey B. Stavenhagen, Sergey Gorlatov, Nadine Tuaillon et al. · Cancer Research · 2007 · 278 citations · Full text

Pharmacy, Immunology, Oncology +17

Effector Cell Recruitment with Novel Fv-based Dual-affinity Re-targeting Protein Leads to Potent Tumor Cytolysis and in Vivo B-cell Depletion

Syd Johnson, Stephen Burke, Ling Huang et al. · Journal of Molecular Biology · 2010 · 192 citations

Medicine, Immunology, Oncology +15

Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma

Chi‐Chao Chan, Defen Shen, Joseph Hackett et al. · Ophthalmology · 2003 · 109 citations

Medicine, Immunology, Ophthalmology +12

MCP-1 expression in endotoxin-induced uveitis.

Nadine Tuaillon, De Fen Shen, Ravi B Berger et al. · PubMed · 2002 · 98 citations

Medicine, Immunology, Pathobiology +17

CD32B, the human inhibitory Fc-γ receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma

Christopher T. Rankin, Maria-Concetta Verı́, Sergey Gorlatov et al. · Blood · 2006 · 88 citations · Full text

Medicine, Hematology, Oncology +16